Tonix Pharmaceuticals

$0.9553
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.06 (-5.77%) Today
-$0.0247 (-2.52%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell TNXP and other stocks, options, and ETFs commission-free!

About TNXP

Tonix Pharmaceuticals Holding Corp. Common Stock, also called Tonix Pharmaceuticals, is a clinical-stage biopharmaceutical company, which focuses on the discovery, acquisition, and development of small molecules and biologics to treat and prevent human disease and alleviate suffering.

CEO
Seth Lederman
Employees
17
Headquarters
Chatham, New Jersey
Founded
2007
Market Cap
317.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
10.00M
High Today
$1.01
Low Today
$0.935
Open Price
$1.00
Volume
13.37M
52 Week High
$2.46
52 Week Low
$0.51

TNXP Earnings

-$5.69
-$3.79
-$1.90
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 11, Pre-Market

You May Also Like

NXGN
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure